Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

DBV Submits VIASKIN Peanut Patch for FDA Approval Following Phase 3 Success

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Potential Breakthrough for Celiac Disease: Teva Antibody Significantly Reduces Gluten-Induced Gut Damage

Rare Antibodies Could Lead to First Targeted Treatment for Alpha-Gal Syndrome

Another Potential Food Allergy Treatment is Snapped Up by Big Pharma

Oral Medication Shows Strong Promise for Moderate to Severe Eczema in...

Antibody May Provide New Treatment for Food Allergies

Broad Spectrum OIT Candidate for Multiple Food Allergies Begins Phase 1/2...

Aquestive Charts Ambitious Path Forward for Sublingual Emergency Epinephrine

Company to Begin Phase 3 Trials of New Peanut Allergy OIT...

Company Licenses Experimental Cancer Treatment to Treat Anaphylaxis

Peanut Allergy Vaccine Takes Another Step with Biomarker Study

Johnson & Johnson COVID-19 Vaccine List of Ingredients

New Microneedle Patch Therapy for Food Allergies Takes Step Forward

Peanut Sublingual Immunotherapy Provides Desensitization to Peanut in Toddlers

Follow Us

Your School On Our Map

Put Your School on the Map